For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250723:nRSW1210Sa&default-theme=true
RNS Number : 1210S CT Global Managed Portfolio - CMPI 23 July 2025
To: RNS
From: CT Global Managed Portfolio Trust PLC (the
'Company')
Date: 23 July 2025
LEI: 213800ZA6TW45NM9YY31
Investment Management Fee
The Board and Columbia Threadneedle Investment Business Limited (the
'Manager') have agreed a reduction in the investment management fee (the
'Fee') with effect from 1 September 2025. The Fee will be reduced to 0.60% per
annum of the net asset value of each portfolio of the Company (rather than
0.65% per annum of the total assets of each portfolio) and there will no
longer be any charge on any assets which are invested in other investment
vehicles managed by the Manager. In aggregate these changes will lead to an
annualised pro forma reduction in the Fee paid to the Manager of approximately
£135,000.
It is the Board's intention to use much of this saving to enhance the
marketing and promotion of the Company in the belief that the scale benefits
that may accrue to shareholders will, in time, more than cover the additional
investment.
Basing the Fee on net asset value rather than total assets better aligns the
interests of the Manager and shareholders, in essence by not charging on any
borrowings, and, while there are merits in the alignment of interests achieved
between the Manager and shareholders by a Fee based on market capitalisation,
the Company's Share Issuance and Buy-back Policy ensures this alignment is
effectively achieved.
For further information please contact:
Adam Norris, Columbia Threadneedle Investment Business
Limited 0131 573 8300
Paul Green, Columbia Threadneedle Investment Business
Limited 0131 573 8300
Sarah Gibbons-Cook, Quill
PR
07702 412680
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END MSCQLLFLEDLBBBX